Advances in PET/CT Imaging for Breast Cancer.
Dorine de JongElise DesperitoKarine A Al FeghaliLaurent DercleRomain-David SebanJeeban P DasHong MaAbin SajanBrian BraumullerConor PrendergastConnie LiouAileen DengTina RoaRandy YehAntoine GirardMary M SalvatoreKathleen M CapaccionePublished in: Journal of clinical medicine (2023)
One out of eight women will be affected by breast cancer during her lifetime. Imaging plays a key role in breast cancer detection and management, providing physicians with information about tumor location, heterogeneity, and dissemination. In this review, we describe the latest advances in PET/CT imaging of breast cancer, including novel applications of 18 F-FDG PET/CT and the development and testing of new agents for primary and metastatic breast tumor imaging and therapy. Ultimately, these radiopharmaceuticals may guide personalized approaches to optimize treatment based on the patient's specific tumor profile, and may become a new standard of care. In addition, they may enhance the assessment of treatment efficacy and lead to improved outcomes for patients with a breast cancer diagnosis.
Keyphrases
- pet ct
- high resolution
- healthcare
- small cell lung cancer
- positron emission tomography
- breast cancer risk
- squamous cell carcinoma
- stem cells
- palliative care
- adipose tissue
- metabolic syndrome
- quality improvement
- type diabetes
- pregnant women
- mesenchymal stem cells
- fluorescence imaging
- skeletal muscle
- social media
- insulin resistance
- label free
- smoking cessation
- cervical cancer screening